Domingo, E., Camps, C., Kaisaki, P., Parsons, M., Mouradov, D., Pentony, M., . . . Tomlinson, I. (2018). Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent. Elsevier.
Chicago Style (17th ed.) CitationDomingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
ציטוט MLADomingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.